Nadia Ghazali Urges Global Oncology Community to Converge Onsite at ASCO 2026: A Pivotal Moment for Equitable Cancer Care

In a world grappling with persistent health disparities, the fight against cancer remains a monumental global challenge. Against this backdrop, a clarion call has been issued by prominent figure Nadia Ghazali, urging the Global Oncology Community of Practice (GOCOP) to convene for a crucial onsite meeting at the highly anticipated American Society of Clinical Oncology (ASCO) Annual Meeting in 2026. This invitation signals a pivotal moment, aiming to harness collective expertise and foster collaborative strategies to advance equitable cancer care worldwide. The convergence at ASCO 2026 is not merely another conference session; it represents a strategic opportunity to consolidate efforts, amplify voices, and accelerate progress in global oncology, leveraging the immense platform provided by one of the world’s leading cancer conferences.

Table of Contents

• Introduction: The Unfolding Horizon of Global Oncology
• The Nexus of Global Oncology: Why ASCO 2026?
  • The American Society of Clinical Oncology (ASCO) Annual Meeting: A Global Beacon
  • Strategic Convergence: Why an Onsite GOCOP Meeting at ASCO is Crucial
• Understanding the Global Oncology Community of Practice (GOCOP)
  • What is a Community of Practice?
  • The Imperative of Global Oncology
  • GOCOP’s Mission and and Impact
• Nadia Ghazali: A Visionary Voice in Global Cancer Care
  • Leadership in Action
  • The Call to Convene: What it Means
• Addressing the Grand Challenges in Global Oncology
  • Bridging the Access Gap: Diagnostics, Treatment, and Palliative Care
  • Workforce Development and Capacity Building
  • Research and Innovation in Diverse Settings
  • Policy, Advocacy, and Sustainable Funding
• The ASCO 2026 Onsite Meeting: A Catalyst for Change
  • Expected Agenda and Discussions
  • Opportunities for Collaboration and Synergy
  • Setting Future Directions and Actionable Outcomes
• Beyond the Meeting: Sustaining Momentum
  • Post-Conference Initiatives and Follow-Up
  • The Long-Term Vision of GOCOP
• Conclusion: A Collective Journey Towards Equitable Cancer Care

Introduction: The Unfolding Horizon of Global Oncology

The global burden of cancer is escalating at an alarming rate, disproportionately affecting low- and middle-income countries (LMICs) where resources are scarce and healthcare infrastructure is often nascent. While breakthroughs in cancer research and treatment continue to emerge, the equitable distribution and implementation of these advancements remain a significant challenge. It is within this complex landscape that the call from Nadia Ghazali for the Global Oncology Community of Practice (GOCOP) to gather at ASCO 2026 resonates with profound significance. This strategic assembly is envisioned as a critical forum to bridge divides, foster innovation, and chart a collective course towards a future where high-quality cancer care is accessible to all, regardless of geographic location or socioeconomic status. The ASCO Annual Meeting, renowned for its scientific rigor and vast global reach, provides an unparalleled platform for such a vital convergence, promising to infuse global oncology initiatives with renewed momentum and strategic direction.

The Nexus of Global Oncology: Why ASCO 2026?

The decision to host a critical onsite meeting of the Global Oncology Community of Practice at the American Society of Clinical Oncology (ASCO) Annual Meeting in 2026 is a calculated and strategic move, designed to maximize impact and engagement. ASCO represents the pinnacle of oncology conferences, offering an unparalleled environment for scientific exchange, networking, and the dissemination of cutting-edge research. Its global footprint and diverse attendee base make it the ideal stage for GOCOP to amplify its mission and mobilize the broader oncology community.

The American Society of Clinical Oncology (ASCO) Annual Meeting: A Global Beacon

Since its inception, the ASCO Annual Meeting has grown to become the world’s largest and most prestigious gathering of oncology professionals. Held annually, it attracts tens of thousands of oncologists, researchers, allied health professionals, industry leaders, and patient advocates from across the globe. The meeting serves as a critical forum for the presentation of groundbreaking clinical trial results, the discussion of emerging therapies, and the refinement of best practices in cancer care. Its comprehensive program covers a vast spectrum of oncology subspecialties, from targeted therapies and immunotherapies to surgical techniques, radiation oncology advancements, and supportive care.

The prestige of ASCO stems from its rigorous scientific review process, ensuring that only the most impactful and methodologically sound research is presented. This commitment to scientific excellence has cemented ASCO’s reputation as a bellwether for the future direction of cancer treatment and research. Beyond the scientific presentations, ASCO facilitates invaluable networking opportunities, allowing clinicians and researchers to forge collaborations, share insights, and discuss challenges and solutions with peers from diverse clinical and research settings. It is a melting pot of ideas, where the collective wisdom of the global oncology community converges to push the boundaries of cancer medicine. For those dedicated to global oncology, ASCO offers a unique window into the latest advancements, which can then be adapted and implemented in varied resource settings.

Strategic Convergence: Why an Onsite GOCOP Meeting at ASCO is Crucial

Hosting the Global Oncology Community of Practice’s onsite meeting within the framework of ASCO 2026 offers distinct strategic advantages. Firstly, it provides an immediate and expansive audience of engaged oncology professionals who are already invested in advancing cancer care. This inherent audience eliminates the need to draw participants to a separate event, maximizing attendance and ensuring a broad reach for GOCOP’s discussions and calls to action. By situating its meeting within ASCO, GOCOP effectively leverages the conference’s existing infrastructure, logistical support, and global communication channels, enhancing its visibility and operational efficiency.

Secondly, the ASCO environment fosters an atmosphere of intense learning and collaboration. Participants attending GOCOP’s session will be fresh from exposure to the latest research and clinical innovations presented at the main conference. This context can significantly enrich discussions, allowing GOCOP members to consider how new discoveries might be applied or adapted within global health frameworks, particularly in resource-constrained environments. It encourages a cross-pollination of ideas between cutting-edge research primarily originating from high-income countries and the practical realities and innovative solutions being developed in LMICs.

Finally, an onsite meeting allows for invaluable face-to-face interactions that go beyond what virtual platforms can offer. The nuances of discussion, the spontaneous networking, and the deeper relationship building that occur in person are crucial for building a robust and cohesive community of practice. For a community dedicated to complex global health challenges, personal connections can significantly accelerate trust-building, facilitate resource sharing, and strengthen collaborative ventures, leading to more sustainable and impactful outcomes in the long run. The synergy created by bringing together the specific focus of GOCOP with the broader influence of ASCO is expected to generate a powerful catalyst for change in global cancer care.

Understanding the Global Oncology Community of Practice (GOCOP)

To fully appreciate the significance of Nadia Ghazali’s call, it is essential to understand the fundamental concept of a Community of Practice and the specific challenges and objectives that define the Global Oncology Community of Practice (GOCOP).

What is a Community of Practice?

A Community of Practice (CoP) is a group of people who share a concern or a passion for something they do and learn how to do it better as they interact regularly. This concept, popularized by theorists Etienne Wenger and Jean Lave, emphasizes three core elements: the **domain**, which is the shared interest or problem; the **community**, referring to the relationships and interactions among members; and the **practice**, representing the shared repertoire of resources, experiences, and tools developed by the community. In healthcare, CoPs are vital for knowledge management, innovation, and professional development.

For a specialized field like global oncology, a CoP offers numerous benefits. It facilitates the sharing of best practices and lessons learned across diverse geographical and resource settings, which is crucial given the varied contexts of cancer care worldwide. It provides a platform for problem-solving, allowing members to collectively address complex challenges such as drug access, workforce shortages, or adapting clinical guidelines. CoPs also foster capacity building through mentorship, training, and collaborative projects, empowering members with new skills and knowledge. Ultimately, a strong CoP acts as a force multiplier, transforming individual efforts into collective impact and accelerating progress in its domain.

The Imperative of Global Oncology

Global oncology is a discipline focused on addressing the disparities in cancer care and outcomes across the world, particularly highlighting the inequities faced by LMICs. The imperative for a dedicated focus on global oncology stems from stark statistics: over 70% of global cancer deaths occur in LMICs, despite these regions often having less than 5% of the global oncology resources. This disparity is multifaceted, rooted in socio-economic, political, and systemic issues.

Key challenges include:

• Access to Diagnostics: Many LMICs lack basic diagnostic tools like imaging, pathology labs, and trained personnel, leading to late-stage presentations and poorer prognoses.
• Treatment Gaps: Shortages of essential medicines, lack of access to radiation therapy machines, limited surgical capacity, and a dearth of skilled oncologists mean that effective treatments are often unavailable or unaffordable.
• Infrastructure Deficiencies: Inadequate healthcare facilities, unreliable supply chains, and insufficient data collection systems hinder effective cancer control.
• Workforce Shortages: A critical lack of trained oncologists, nurses, pathologists, and palliative care specialists exacerbates the problem.
• Preventable Cancers: Many cancers in LMICs are linked to infectious agents (e.g., HPV, HBV) or lifestyle factors (e.g., tobacco, obesity), highlighting the need for robust prevention and early detection programs.
• Financial Toxicity: Even when treatments are available, the cost can be catastrophic for patients and families, pushing them deeper into poverty.

Addressing these challenges requires a concerted, coordinated global effort, recognizing that cancer is not just a medical problem but also a significant developmental issue with profound societal and economic consequences.

GOCOP’s Mission and Impact

The Global Oncology Community of Practice (GOCOP) emerges as a vital response to these pressing global challenges. Its overarching mission is to unite diverse stakeholders—clinicians, researchers, policymakers, advocates, and patients—from across the world to collaborate on improving cancer care in all settings, with a particular emphasis on addressing the needs of LMICs. GOCOP aims to bridge the knowledge gap, facilitate resource sharing, and advocate for equitable cancer policies and funding.

The impact of a thriving GOCOP can be seen in several key areas:

• Knowledge Exchange: Creating platforms for sharing context-specific solutions, clinical protocols adapted for low-resource settings, and innovative delivery models.
• Capacity Building: Developing educational programs, mentorship opportunities, and training initiatives to strengthen the oncology workforce in underserved regions.
• Standardization and Harmonization: Working towards consensus on guidelines and best practices that are both evidence-based and culturally/resource-appropriate.
• Research Collaboration: Fostering multinational research projects focused on LMIC-specific cancer burdens, epidemiology, and treatment optimization.
• Advocacy and Policy Influence: Providing a unified voice to advocate for increased investment in global cancer control, integration of cancer services into primary healthcare, and policies that improve access to essential medicines and technologies.
• Innovation: Incubating and disseminating novel approaches to prevention, early detection, diagnosis, treatment, and palliative care that are scalable and sustainable in diverse environments.

Through these efforts, GOCOP seeks to cultivate a global ecosystem of support and collaboration, ensuring that the advancements in oncology benefit humanity as a whole, not just a privileged few.

Nadia Ghazali: A Visionary Voice in Global Cancer Care

The significance of the ASCO 2026 meeting for the Global Oncology Community of Practice is underscored by the leadership of Nadia Ghazali. While specific biographical details are often not broadly publicized in initial announcements, her prominent role in issuing this call signals her as a key advocate and influential figure within the realm of global cancer care. Her initiative highlights the critical role individual leadership plays in galvanizing collective action and shaping the trajectory of international health endeavors.

Leadership in Action

In the complex and often fragmented landscape of global health, effective leadership is paramount. Nadia Ghazali’s call to convene GOCOP at ASCO 2026 positions her as a proactive and visionary leader, one who understands the strategic importance of bringing diverse stakeholders together at a critical juncture. Her actions reflect a deep commitment to fostering collaboration and ensuring equity in cancer care, recognizing that sustained progress requires more than just scientific breakthroughs—it demands coordinated global effort and policy alignment.

Leaders in global oncology often navigate a myriad of challenges, including advocating for policy changes, mobilizing resources, building partnerships across continents, and ensuring that scientific advancements are translated into accessible treatments for all populations. A leader like Nadia Ghazali would likely possess a profound understanding of these complexities, drawing upon extensive experience in clinical practice, research, or public health policy. Her role is not just about organizing a meeting, but about setting an agenda, inspiring participation, and guiding the discourse towards actionable outcomes. Such leadership is instrumental in creating the necessary momentum to tackle the formidable disparities in cancer care that persist globally.

The power of individual leadership in driving collective action cannot be overstated. It provides a focal point for efforts, a voice that can articulate the urgent need for change, and a catalyst for bringing disparate groups together under a common banner. Ghazali’s initiative exemplifies this, directing attention to the urgent need for global collaboration in a field where national borders often define the limits of care.

The Call to Convene: What it Means

Nadia Ghazali’s invitation to the Global Oncology Community of Practice to hold an onsite meeting at ASCO 2026 is far more than a logistical arrangement; it is a strategic maneuver imbued with significant meaning and potential impact. It signifies an urgent recognition that despite ongoing efforts, the global oncology community must recalibrate, re-strategize, and re-engage on a unified front to tackle the burgeoning cancer burden, particularly in underserved regions.

The call is, fundamentally, an appeal to translate advocacy into tangible action. By bringing GOCOP to ASCO, Ghazali is effectively placing global oncology at the heart of the international cancer dialogue, ensuring that discussions about cutting-edge science are intrinsically linked to the realities of healthcare delivery worldwide. It means:

• Prioritizing Global Health: Elevating the discourse on global health disparities to a prominent position within the world’s leading oncology conference.
• Mobilizing Expertise: Drawing on the collective intelligence and experience of GOCOP members, enriched by the broader ASCO environment, to identify innovative solutions.
• Fostering Accountability: Creating a platform where commitments can be made, progress reviewed, and future directions for global initiatives solidified.
• Building Consensus: Working towards shared objectives and harmonized approaches among diverse stakeholders.

Ultimately, this call underscores the urgency of addressing global cancer challenges with renewed vigor and a unified strategy. It is an acknowledgment that effective solutions demand collective intelligence, cross-cultural understanding, and sustained collaboration, all facilitated by a focused gathering at a globally recognized event like ASCO.

Addressing the Grand Challenges in Global Oncology

The Global Oncology Community of Practice, as envisioned by leaders like Nadia Ghazali, faces a multifaceted array of grand challenges that necessitate collaborative and innovative solutions. These challenges span the entire spectrum of cancer care, from prevention and early detection to treatment, palliative care, and policy implementation. An onsite meeting at ASCO 2026 provides a critical venue to dissect these issues and forge actionable pathways forward.

Bridging the Access Gap: Diagnostics, Treatment, and Palliative Care

One of the most profound challenges in global oncology is the stark disparity in access to essential services. This gap manifests in several critical areas:

• Diagnostics: In many LMICs, cancer diagnoses occur at advanced stages due to a lack of accessible and affordable screening programs, imaging technologies (CT, MRI, PET scans), and pathology services. Basic histopathology is often unavailable or relies on overworked pathologists in distant centralized facilities, leading to significant delays and misdiagnoses. Bridging this gap requires investment in point-of-care diagnostics, simplified screening protocols, and telepathology solutions.
• Therapeutics: Access to effective cancer treatments, including chemotherapy, targeted therapies, immunotherapies, and surgical interventions, is severely limited. High costs, patent barriers, unreliable supply chains, and inadequate infrastructure prevent many patients from receiving life-saving treatments. GOCOP discussions would likely focus on strategies for drug procurement, local manufacturing, patent pooling, and the development of essential medicines lists tailored for global contexts.
• Surgical and Radiation Oncology: These modalities are foundational to cancer cure and control, yet access to skilled surgeons, operating theaters, radiation oncologists, and functional radiotherapy machines is acutely scarce in many regions. The community must explore innovative models for training, equipment donation programs, and regional centers of excellence to address these gaps.
• Palliative Care: Often overlooked, palliative care is an essential component of comprehensive cancer management, providing pain relief and quality of life support. Access to opioids and trained palliative care providers is extremely limited in many parts of the world. GOCOP can advocate for the integration of palliative care early in the cancer trajectory and promote policies that facilitate access to essential pain medications.

Workforce Development and Capacity Building

A critical bottleneck in global cancer control is the severe shortage of skilled healthcare professionals. This includes not only oncologists but also oncology nurses, pathologists, radiation therapists, pharmacists, public health specialists, and data managers. Even when trained, retention can be a challenge due to poor working conditions and limited opportunities.

Addressing this requires:

• Training and Education: Developing and implementing culturally appropriate training programs, both locally and through international partnerships. This includes specialized oncology fellowships, distance learning initiatives, and hands-on workshops.
• Mentorship and Peer Support: Establishing mentorship programs that connect experienced professionals with those in developing contexts, fostering a sense of community and providing ongoing guidance.
• Task Shifting and Community Health Workers: Exploring models where non-specialist health workers can be trained to perform certain oncology-related tasks, such as screening, patient navigation, and supportive care, thereby extending the reach of limited specialist workforces.
• Creating Enabling Environments: Advocating for policies that improve working conditions, offer professional development opportunities, and provide fair compensation to retain skilled healthcare providers in their home countries.

Research and Innovation in Diverse Settings

While global oncology often focuses on implementing existing solutions, there is a profound need for research and innovation that is relevant to diverse settings. Much of current cancer research is conducted in high-income countries, often with patient populations and disease patterns that may not fully reflect the global burden of cancer.

Key areas for focus include:

• Locally Relevant Research: Encouraging and funding research into the epidemiology of cancers prevalent in LMICs (e.g., cervical, liver, gastric cancers), understanding unique risk factors, and investigating the genetic and biological characteristics of these cancers in diverse populations.
• Clinical Trials Adaptation: Designing and conducting clinical trials that are appropriate for resource-constrained environments, evaluating affordable therapies, and assessing the effectiveness of interventions in real-world settings.
• Implementation Science: Researching the most effective strategies to implement proven interventions in diverse healthcare systems, identifying barriers, and facilitating successful adoption.
• Data Collection and Registries: Investing in robust cancer registries and data collection systems to accurately track cancer incidence, prevalence, and outcomes, which are essential for policy planning and resource allocation.

Policy, Advocacy, and Sustainable Funding

Sustainable change in global oncology ultimately hinges on supportive policies and consistent funding. This involves efforts at national and international levels.

• National Cancer Control Plans (NCCPs): Advocating for every country to develop and implement comprehensive, funded NCCPs that integrate prevention, early detection, diagnosis, treatment, and palliative care into their national health strategies.
• International Aid and Philanthropy: Engaging international bodies, philanthropic organizations, and donor countries to increase and sustain funding for global cancer initiatives, ensuring that cancer is recognized as a global health priority alongside infectious diseases.
• Integration into Universal Health Coverage (UHC): Championing the inclusion of essential cancer services within universal health coverage schemes, making care affordable and accessible to all citizens.
• Advocacy for Essential Medicines: Working with governments and pharmaceutical companies to ensure the availability and affordability of essential cancer medicines through mechanisms like tiered pricing, voluntary licensing, and robust procurement strategies.

The ASCO 2026 GOCOP meeting is poised to tackle these formidable challenges head-on, fostering discussions and collaborations that can lead to concrete, implementable solutions and a more equitable distribution of cancer care globally.

The ASCO 2026 Onsite Meeting: A Catalyst for Change

The decision to host the Global Oncology Community of Practice’s onsite meeting at ASCO 2026 is strategic, aiming to maximize impact and catalyze significant advancements. This convergence is not merely a scheduled gathering but a deliberately orchestrated event designed to be a crucible for innovation, collaboration, and decisive action in global cancer care.

Expected Agenda and Discussions

While the detailed agenda for the GOCOP meeting at ASCO 2026 will undoubtedly evolve as the date approaches, based on the pressing issues in global oncology and the community’s mission, several key themes and discussion points are anticipated. These discussions will likely be structured around plenary sessions, interactive workshops, and expert panel discussions, designed to elicit concrete strategies and solutions.

Expected topics include:

• Innovative Models of Care Delivery: Exploring novel approaches to deliver cancer care in resource-constrained settings, such as hub-and-spoke models, digital health solutions (tele-oncology), and integrated primary care initiatives.
• Leveraging Artificial Intelligence (AI) in Global Oncology: Discussing the potential of AI for early diagnosis (e.g., image analysis for pathology), treatment planning, and personalized medicine, while also addressing challenges of data infrastructure and ethical implementation in diverse contexts.
• Strengthening National Cancer Control Plans (NCCPs): Reviewing existing NCCPs, identifying best practices, and developing strategies to secure sustainable funding and political commitment for their implementation.
• Access to Essential Oncology Medicines: Debating mechanisms to improve the availability and affordability of life-saving cancer drugs, including pooled procurement, regional manufacturing, and policy advocacy for generic drug access.
• Cancer Prevention and Early Detection Strategies: Focusing on cost-effective, scalable interventions for preventable cancers (e.g., HPV vaccination, tobacco cessation, screening programs for breast and cervical cancer) and community-based outreach.
• Data Science and Cancer Registries: Discussing the critical importance of robust data collection to inform policy, resource allocation, and research, and exploring innovative methods for establishing and maintaining cancer registries in LMICs.
• Integrating Palliative Care and Survivorship: Emphasizing the need to embed comprehensive palliative care and survivorship programs into routine oncology practice, ensuring dignity and quality of life for all patients.

These discussions will be framed by a commitment to equity, sustainability, and local relevance, ensuring that proposed solutions are both ambitious and implementable.

Opportunities for Collaboration and Synergy

The greatest strength of an onsite GOCOP meeting within ASCO lies in its unparalleled opportunities for collaboration and synergy. Bringing together a focused group of global oncology experts with the broader ASCO community creates a powerful dynamic:

• Interdisciplinary Networking: Clinicians, researchers, policymakers, patient advocates, and industry representatives from various backgrounds and regions can interact directly, fostering a rich exchange of ideas and perspectives. This cross-pollination is essential for tackling complex global health issues.
• Forming New Partnerships: The informal interactions at ASCO can lead to the formation of new research collaborations, clinical trial partnerships, and advocacy alliances that might not materialize in a virtual setting. These partnerships are critical for sharing resources, expertise, and infrastructure.
• Consolidating Existing Collaborations: For established initiatives, the meeting offers a chance for existing partners to reconvene, review progress, troubleshoot challenges, and plan future phases of their collaborative work.
• Leveraging ASCO’s Influence: GOCOP can tap into ASCO’s vast network and advocacy power to amplify its messages and influence global health policy. Presentations at ASCO by GOCOP leaders can draw attention to critical issues and rally broader support from the international oncology community.
• Resource Mobilization: Direct interactions with funding bodies, philanthropic organizations, and pharmaceutical companies present opportunities for securing essential resources and support for global oncology initiatives.

The synergy created by these interactions is expected to accelerate the development and implementation of effective strategies to combat cancer disparities globally.

Setting Future Directions and Actionable Outcomes

A primary objective of the GOCOP meeting at ASCO 2026 is to move beyond discussion to define clear future directions and generate actionable outcomes. The meeting is not just about identifying problems but about collectively designing solutions that can be implemented and sustained.

Anticipated outcomes include:

• Development of Roadmaps: Creating concrete roadmaps for specific initiatives, such as expanding access to HPV vaccination, establishing regional training centers, or developing guidelines for affordable cancer diagnostics.
• Policy Recommendations: Formulating evidence-based policy recommendations for national governments and international organizations to improve cancer control and integrate it into broader health agendas.
• Collaborative Research Agendas: Identifying priority areas for global oncology research and outlining frameworks for collaborative studies that address specific needs in LMICs.
• Resource Mobilization Strategies: Outlining strategies for securing sustainable funding, including engaging new donors, fostering public-private partnerships, and advocating for increased governmental investment.
• Capacity Building Frameworks: Designing scalable frameworks for workforce training and mentorship programs that can be adapted to various contexts.
• Commitment Declarations: Potentially culminating in a declaration of commitment from participating organizations and individuals to specific goals and timelines for advancing global cancer equity.

By focusing on actionable plans and measurable objectives, the GOCOP meeting aims to ensure that its impact extends far beyond the duration of the conference, initiating a sustained trajectory of progress in global oncology.

Beyond the Meeting: Sustaining Momentum

The success of the Global Oncology Community of Practice’s onsite meeting at ASCO 2026 will not solely be judged by the discussions held or the immediate outcomes achieved, but by its lasting legacy. Sustaining the momentum generated at such a high-profile event is crucial to translate commitments into tangible improvements in cancer care worldwide. This requires deliberate planning for post-conference initiatives and a clear, long-term vision for GOCOP’s continued evolution.

Post-Conference Initiatives and Follow-Up

To ensure that the energy and insights from the ASCO 2026 meeting are not fleeting, a robust plan for follow-up activities will be essential. These initiatives will serve to disseminate findings, consolidate partnerships, and monitor progress on agreed-upon actions.

• Dissemination of Findings and Recommendations: A comprehensive report summarizing the key discussions, conclusions, and actionable recommendations should be promptly published and widely disseminated through academic journals, public health networks, and GOCOP’s own communication channels. This ensures that insights reach a broader audience, including those who could not attend.
• Formation of Working Groups: The meeting should ideally lead to the establishment of dedicated working groups focused on specific challenges or initiatives identified during the sessions. These groups, comprising experts from diverse backgrounds, would be tasked with developing detailed implementation plans, drafting policy briefs, or initiating pilot projects. They would continue to collaborate virtually, with regular check-ins and progress reports.
• Virtual Platforms for Continued Collaboration: Leveraging online platforms (e.g., dedicated forums, webinars, shared document repositories) is crucial for maintaining communication and collaboration among GOCOP members post-conference. These platforms can facilitate ongoing knowledge exchange, mentorship, and project coordination across geographical boundaries.
• Monitoring and Evaluation Frameworks: Establishing clear metrics and a framework for monitoring the progress and impact of GOCOP’s initiatives is vital. Regular evaluations will help assess the effectiveness of interventions, identify areas for improvement, and demonstrate accountability to stakeholders and funders.
• Advocacy Campaigns: The collective voice of GOCOP, bolstered by the consensus reached at ASCO, can be channeled into targeted advocacy campaigns aimed at national governments, international health organizations, and pharmaceutical companies to influence policy and resource allocation.

These post-conference efforts will transform the meeting from a standalone event into a pivotal milestone within a continuous cycle of learning, action, and improvement.

The Long-Term Vision of GOCOP

Beyond ASCO 2026, the Global Oncology Community of Practice envisions a sustainable, resilient, and responsive ecosystem dedicated to equitable cancer care. This long-term vision encompasses several core tenets:

• Continuous Learning and Adaptation: GOCOP must remain agile, continuously learning from new research, adapting to evolving global health landscapes, and incorporating feedback from its diverse members. This includes embracing new technologies and methodologies to enhance its operations and impact.
• Building a Robust Global Network: The community aims to expand its reach, welcoming new members and forging alliances with other global health initiatives, patient advocacy groups, and professional organizations. A strong, interconnected network is essential for comprehensive impact.
• Empowering Local Leadership: A key objective is to foster and empower local leadership in global oncology, ensuring that solutions are contextually relevant and driven by those most directly affected by the challenges. This includes developing mentorship programs and providing resources for local capacity building.
• Championing Health Equity: At its core, GOCOP’s vision is to champion health equity, relentlessly advocating for a world where cancer outcomes are not predetermined by one’s birthplace, income, or access to resources. This involves addressing systemic barriers and advocating for universal access to quality cancer care.
• Influencing Global Health Agendas: GOCOP seeks to firmly establish cancer control as a core component of the global health and development agenda, ensuring it receives adequate political attention and financial investment, akin to other major global health threats.

Nadia Ghazali’s call for the ASCO 2026 meeting is thus a critical step in this ongoing journey, reinforcing GOCOP’s role as a vital force for change and solidarity in the global fight against cancer. It underscores a collective commitment to a future where cancer care is a universal right, not a privilege.

Conclusion: A Collective Journey Towards Equitable Cancer Care

Nadia Ghazali’s imperative for the Global Oncology Community of Practice to converge onsite at ASCO 2026 marks a moment of profound strategic importance for the future of cancer care worldwide. In a landscape increasingly defined by both rapid scientific progress and widening health disparities, the need for a unified, collaborative, and action-oriented global oncology community has never been more critical. By leveraging the unparalleled platform of ASCO, this meeting is poised to be a crucible of ideas, a forge for partnerships, and a launchpad for initiatives designed to dismantle the barriers to equitable cancer treatment and prevention.

This gathering represents more than just a conference; it embodies a collective reaffirmation of purpose—to address the grand challenges spanning access to diagnostics and therapeutics, workforce development, locally relevant research, and sustainable policy and funding. The insights gained, the collaborations forged, and the action plans developed at ASCO 2026 are expected to resonate far beyond the meeting halls, driving tangible improvements in the lives of millions affected by cancer, particularly in the most vulnerable regions. Nadia Ghazali’s vision underscores a powerful truth: that despite the enormity of the global cancer burden, through shared commitment, collective intelligence, and sustained effort, a future where high-quality, equitable cancer care is a reality for all humanity is not merely an aspiration, but an achievable goal. The journey towards this future takes a significant step forward with this pivotal convergence at ASCO 2026, heralding a renewed era of global solidarity in the fight against cancer.